3.15 pm Panel Discussion: Designing Therapies with Novel Mechanisms & Predictive Biomarkers to Holistically Improve Treatment for Better Patient Outcomes
Time: 3:15 pm
day: Combination & Sequential Therapy Focus Day
Details:
- Integrating the design of therapies involving novel mechanisms with new, predictive biomarkers to provide a more precise and efficient approach to drug discovery and development for earlier identification of responders and non-responders
- Leveraging cutting-edge understanding of MASH pathogenesis to design innovative therapies to target the root causes of the disease for more effective treatments that can holistically improve patient outcomes
- Developing and validating novel predictive biomarkers alongside new therapeutic candidates for early and accurate identification of patient response for more streamlined clinical trials and impactful MASH therapies
